Anika Therapeutics (ANIK) Finished Goods (2011 - 2018)

Anika Therapeutics (ANIK) has 8 years of Finished Goods data on file, last reported at $4.6 million in Q3 2018.

• On a quarterly basis, Finished Goods fell 20.31% year-over-year to $4.6 million in Q3 2018; TTM through Sep 2018 was $4.6 million, a 20.31% decrease from a year earlier, with the FY2017 full-year figure at $4.7 million, up 3.02% from the prior year.
• Finished Goods for Q3 2018 stood at $4.6 million, down from $5.2 million in the prior quarter.
• Over the last five years, Finished Goods for ANIK reached as high as $6.8 million in Q1 2018 and fell as low as $3.1 million in Q1 2015.
• Historically, Finished Goods has averaged $4.6 million across 5 years, with a median of $4.6 million in 2018.
• Across the five-year window, Finished Goods surged 147.88% in 2014 and slumped 41.93% in 2015, its largest moves.
• Year by year, Finished Goods stood at $3.2 million in 2014, then gained by 9.3% to $3.5 million in 2015, then advanced by 29.64% to $4.5 million in 2016, then grew by 3.02% to $4.7 million in 2017, then fell by 0.81% to $4.6 million in 2018.
• Per Business Quant data, the three most recent Finished Goods figures were $4.6 million in Q3 2018, $5.2 million in Q2 2018, and $6.8 million in Q1 2018.